altRX review
altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound — the most comprehensive brand-name lineup in…
Est. first month
From $149/mo (starting dose, compounded)
- Semaglutide
- From $149/mo (starting dose, compounded)
- Tirzepatide
- From $249/mo (starting dose, compounded)
- Coverage
- Coverage not published
- Brand-name
- Yes
The Value Score card
altRX scored on our six published factors. See the methodology.
Why it's a deal
- Offers all four brand-name FDA-approved GLP-1s (Mounjaro, Ozempic, Wegovy, Zepbound) — the most comprehensive brand-name access we've reviewed
- LegitScript Certified with a publicly verifiable seal
- Publishes the FDA compounded-medication disclaimer
- Transparent pricing across all six product tiers (compounded plus four brand-name)
- All-inclusive pricing — consult, prescription, and shipping with no hidden fees
Read the fine print
- States-served list not disclosed
- 503A/503B pharmacy partner not named (only 'multiple USA-certified pharmacies')
- 503A vs 503B designation not specified
- No named medical director
- Corporate physical address not disclosed
The bottom line
Best for: Shoppers who want the only platform offering all four brand-name GLP-1s plus compounded. altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound — the most comprehensive brand-name lineup in…
Ranked #187 of 395 programs we track — see our #1 deal, CoreAge Rx, for comparison.
Compare with other deals
The programs scoring closest to altRX, out of 394 others we track.
Shopping altRX against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs altRX, and every program that undercuts or outscores it is ranked on the altRX alternatives board.
- $225/moTru2u— Tru2u is a US direct-to-consumer telehealth and wellness store offering provider-guided compounded GLP-1 weight-loss therapy alongside hair, skincare, and supplement lines.73/100
- From $170/mo (compounded)YourHealthRx— YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network.73/100
- $65/moPrimary Clinic (Direct GLP)— The cheapest headline number here — $65 semaglutide — but it's a small-clinic, 10-state offer we flag as a teaser to verify, not a sure thing.73/100
- From $179/mo (compounded)Avono Health— Fully online compounded GLP-1 telehealth with transparent, tiered pricing — microdose and standard semaglutide and tirzepatide in both injection and oral forms — plus US-licensed clinicians, 24/7 messaging…72/100
- From $196/mo (starting dose, compounded)Clinic Secret— Clinic Secret (clinicsecret.com), launched late 2025, is a functioning US GLP-1 telehealth platform offering compounded semaglutide and tirzepatide for weight loss, plus a pentadeca arginate peptide.72/100
- From $149/mo (quarterly plan, compounded)Coivas— Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.72/100
More programs we track (24)
- #1 CoreAge Rx93
- #2 Ondra Health92
- #4 Vitara RX91
- #5 Gimme Care91
- #7 Alan Meds90
- #3 Trimi Health89
- #10 Precision Telemed89
- #11 bmiMD89
- #12 Care Clinics89
- #6 Oak88
- #16 Live Vital88
- #17 AmberHealth88
- #18 Fresh Day Meds88
- #8 Sesame Care87
- #9 Strut Health87
- #22 EverSlim87
- #23 NewSelf87
- #24 Vaylen87
- #25 Mint Med87
- #13 HealthRX86
- #14 RxSpan MD86
- #15 Sprout Health86
- #28 Bionomy Health86
- #29 BetterMe Rx86
364 more are reviewed too — see every GLP-1 program we track, ranked.
Pricing and coverage on this page were read from altRX's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on altRX's site. Not medical advice; see our disclosure.